SPHK2
Sphingosine kinase 2
Also known as: SPHK2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRA0
- Gene
- SPHK2
- Ensembl
- ENSG00000063176
- Chromosome
- 19
- Canonical length
- 654 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes one of two sphingosine kinase isozymes that catalyze the phosphorylation of sphingosine into sphingosine 1-phosphate. Sphingosine 1-phosphate mediates many cellular processes including migration, proliferation and apoptosis, and also plays a role in several types of cancer by promoting angiogenesis and tumorigenesis. The encoded protein may play a role in breast cancer proliferation and chemoresistance. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
654 residues, UniProt reviewed canonical sequence.
>Q9NRA0|SPHK2
1 MNGHLEAEEQ QDQRPDQELT GSWGHGPRST LVRAKAMAPP PPPLAASTPL LHGEFGSYPA
61 RGPRFALTLT SQALHIQRLR PKPEARPRGG LVPLAEVSGC CTLRSRSPSD SAAYFCIYTY
121 PRGRRGARRR ATRTFRADGA ATYEENRAEA QRWATALTCL LRGLPLPGDG EITPDLLPRP
181 PRLLLLVNPF GGRGLAWQWC KNHVLPMISE AGLSFNLIQT ERQNHARELV QGLSLSEWDG
241 IVTVSGDGLL HEVLNGLLDR PDWEEAVKMP VGILPCGSGN ALAGAVNQHG GFEPALGLDL
301 LLNCSLLLCR GGGHPLDLLS VTLASGSRCF SFLSVAWGFV SDVDIQSERF RALGSARFTL
361 GTVLGLATLH TYRGRLSYLP ATVEPASPTP AHSLPRAKSE LTLTPDPAPP MAHSPLHRSV
421 SDLPLPLPQP ALASPGSPEP LPILSLNGGG PELAGDWGGA GDAPLSPDPL LSSPPGSPKA
481 ALHSPVSEGA PVIPPSSGLP LPTPDARVGA STCGPPDHLL PPLGTPLPPD WVTLEGDFVL
541 MLAISPSHLG ADLVAAPHAR FDDGLVHLCW VRSGISRAAL LRLFLAMERG SHFSLGCPQL
601 GYAAARAFRL EPLTPRGVLT VDGEQVEYGP LQAQMHPGIG TLLTGPPGCP GREPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPHK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 38 nTPM
- hippocampal formation: 38 nTPM
- midbrain: 37 nTPM
- liver: 31 nTPM
- spinal cord: 24 nTPM
- kidney: 24 nTPM
Single-cell type
- retinal bipolar cells: 60 nCPM
- cone photoreceptor cells: 52 nCPM
- enterocytes: 50 nCPM
- rod photoreceptor cells: 45 nCPM
- retinal horizontal cells: 42 nCPM
- müller glia: 38 nCPM
Immune cell
- basophil: 12 nTPM
- naive B-cell: 8.6 nTPM
- intermediate monocyte: 7.1 nTPM
- classical monocyte: 6.2 nTPM
- non-classical monocyte: 6.2 nTPM
- NK-cell: 5.7 nTPM
Brain region
- pons: 75 nTPM
- medulla oblongata: 65 nTPM
- midbrain: 63 nTPM
- thalamus: 62 nTPM
- cerebral cortex: 58 nTPM
- hippocampal formation: 52 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.32
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood vessel development
- brain development
- cell population proliferation
- cellular response to phorbol 13-acetate 12-myristate
- female pregnancy
- intracellular signal transduction
- negative regulation of cell growth
- positive regulation of apoptotic process
- positive regulation of cell population proliferation
- positive regulation of ceramide biosynthetic process
- positive regulation of cytokine production involved in immune response
- positive regulation of interleukin-13 production
- positive regulation of interleukin-6 production
- positive regulation of mast cell degranulation
- positive regulation of tumor necrosis factor production
- regulation of canonical NF-kappaB signal transduction
- regulation of cytochrome-c oxidase activity
- regulation of reactive oxygen species biosynthetic process
- sphingolipid biosynthetic process
- sphingosine biosynthetic process
- sphingosine metabolic process
- transcription initiation-coupled chromatin remodeling
- positive regulation of mast cell activation involved in immune response
- regulation of ATP biosynthetic process
- sphinganine-1-phosphate biosynthetic process
Molecular functions
- ATP binding
- histone binding
- lipid kinase activity
- small GTPase binding
- sphingosine kinase activity
- sphingosine-1-phosphate receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Diacylglycerol kinase, catalytic domain
- NAD kinase/diacylglycerol kinase-like domain superfamily
- Inorganic polyphosphate/ATP-NAD kinase, N-terminal
- Lipid Phosphate Formation and Regulation
- Diacylglycerol kinase catalytic domain
- YegS/DAGK, C-terminal domain
- YegS C-terminal NAD kinase beta sandwich-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SPHK2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPHK2 as an antibody target. Whether an autoantibody or antibody against SPHK2 could matter depends on whether native SPHK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPHK2 is annotated at the cell surface, where native SPHK2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SPHK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...